Amyloid pathology and protein kinase C (PKC): Possible therapeutics effects of PKC activators

Ana Olariu, Kiyofumi Yamada, Toshitaka Nabeshima

研究成果: Review article査読

20 被引用数 (Scopus)

抄録

Amyloid β-protein (Aβ) is one of the most studied peptides in human neurodegenerative disorders. Although much has been learned about the biochemistry of this peptide, fundamental questions such as when and how the Aβ becomes pathologic remain unanswered. In this article we review the recent findings on the biology and pathology of Aβ and the role protein kinase C (PKC) plays in these processes. The potential neuroprotective role of PKC and the possible therapeutic effects of PKC activators in Alzheimer's disease (AD) will be discussed. Briefly, comments will be also addressed on the role of PKC in cell death and neurogenesis in AD.

本文言語English
ページ(範囲)1-5
ページ数5
ジャーナルJournal of Pharmacological Sciences
97
1
DOI
出版ステータスPublished - 01-2005

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

フィンガープリント 「Amyloid pathology and protein kinase C (PKC): Possible therapeutics effects of PKC activators」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル